María Teresa Alonzo-Castillo

María Teresa Alonzo-Castillo

Auto-generated profile, based on publicly available information

María Teresa Alonzo-Castillo

Department of Psychiatry, Vall d'Hebron Hospital Universitari, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2025 in JMIR Mental Health
Verified
Journal Article
Open access
PMPatricia Laura Maran
Patricia Laura Maran
María Dolores BraquehaisMaría Dolores Braquehais
María Dolores Braquehais
AVAlexandra Vlaic
Alexandra Vlaic
MAMaría Teresa Alonzo-Castillo
María Teresa Alonzo-Castillo
JVJúlia Vendrell-Serres
Júlia Vendrell-Serres
ARAmanda Rodriguez-Urrutia
Amanda Rodriguez-Urrutia
Background: Despite the high prevalence and significant burden of depression, underdiagnosis remains a persistent challenge. Automatic speech analysis (ASA) has emerged as a promising method for depression assessment. However, a comprehensive quantitative synthesis evaluating its diagnostic accuracy is still lacking. Objective: This systematic review and meta-analysis aimed to assess the diagnostic performance of ASA in detecting depression, considering both machine learning and deep learning approaches. Methods: We conducted a systematic search across 8 databases, including MEDLINE, PsycInfo, Embase, CINAHL, IEEE Xplore, ACM Digital Library, Scopus, and Google Scholar from January 2013 to April 1, 2025. We included studies published in English that evaluated the accuracy of ASA for detecting depression, and reported performance metrics such as accuracy, sensitivity, specificity, precision, or confusion matrices. Study quality was assessed using a modified version of the Quality Assessment of Studies of Diagnostic Accuracy-Revised. A 3-level meta-analysis was performed to estimate the pooled highest and lowest accuracy, sensitivity, specificity, and precision. Meta-regressions and subgroup analyses were performed to explore heterogeneity across various factors, including type of publication, artificial intelligence algorithms, speech features, speech-eliciting tasks, ground truth assessment, validation approach, dataset, dataset language, participants’ mean age, and sample size. Results: Of the 1345 records identified, 105 studies met the inclusion criteria. The pooled mean of the highest accuracy, sensitivity, specificity, and precision were 0.81 (95% CI 0.79 to 0.83), 0.84 (95% CI 0.81 to 0.86), 0.83 (95% CI 0.79 to 0.86), and 0.81 (95% CI 0.77 to 0.84), respectively, whereas the pooled mean of the lowest accuracy, sensitivity, specificity, and precision were 0.66 (95% CI 0.63 to 0.69), 0.63 (95% CI 0.58 to 0.68), 0.60 (95% CI 0.55 to 0.66), and 0.64 (95% CI 0.58 to 0.70), respectively. Conclusions: ASA shows promise as a method for detecting depression, though its readiness for clinical application as a standalone tool remains limited. At present, it should be regarded as a complementary method, with potential applications across diverse contexts. Further high-quality, peer-reviewed studies are needed to support the development of robust, generalizable models and to advance this emerging field. Trial Registration: PROSPERO CRD42023444431; https://www.crd.york.ac.uk/PROSPERO/view/CRD42023444431

22 April 2025 in Research in Autism
Verified
Journal Article
Open access
JLJorge Lugo-Marín
Jorge Lugo-Marín
ISImanol Setien-Ramos
Imanol Setien-Ramos
TATeresa Alonzo-Castillo
Teresa Alonzo-Castillo
AGAina García-Martínez
Aina García-Martínez
MJMaría José Jurado-Luque
María José Jurado-Luque
LGLaura Gisbert-Gustemps
Laura Gisbert-Gustemps

23 October 2024 in JMIR Preprints
Verified
Preprint
Open access
PMPatricia Laura Maran
Patricia Laura Maran
María Dolores BraquehaisMaría Dolores Braquehais
María Dolores Braquehais
AVAlexandra Vlaic
Alexandra Vlaic
MAMaría Teresa Alonzo-Castillo
María Teresa Alonzo-Castillo
JVJúlia Vendrell-Serres
Júlia Vendrell-Serres
ARAmanda Rodriguez-Urrutia
Amanda Rodriguez-Urrutia
BACKGROUND Despite the high prevalence and significant burden of depression, underdiagnosis remains a persistent challenge. Automatic speech analysis (ASA) has emerged as a promising method for depression assessment. However, a comprehensive quantitative synthesis evaluating its diagnostic accuracy is still lacking. OBJECTIVE This systematic review and meta-analysis aimed to assess the diagnostic performance of ASA in detecting depression, considering both machine learning and deep learning approaches. METHODS We conducted a systematic search across 8 databases, including MEDLINE, PsycInfo, Embase, CINAHL, IEEE Xplore, ACM Digital Library, Scopus, and Google Scholar from January 2013 to April 1, 2025. We included studies published in English that evaluated the accuracy of ASA for detecting depression, and reported performance metrics such as accuracy, sensitivity, specificity, precision, or confusion matrices. Study quality was assessed using a modified version of the Quality Assessment of Studies of Diagnostic Accuracy-Revised. A 3-level meta-analysis was performed to estimate the pooled highest and lowest accuracy, sensitivity, specificity, and precision. Meta-regressions and subgroup analyses were performed to explore heterogeneity across various factors, including type of publication, artificial intelligence algorithms, speech features, speech-eliciting tasks, ground truth assessment, validation approach, dataset, dataset language, participants’ mean age, and sample size. RESULTS Of the 1345 records identified, 105 studies met the inclusion criteria. The pooled mean of the highest accuracy, sensitivity, specificity, and precision were 0.81 (95% CI 0.79 to 0.83), 0.84 (95% CI 0.81 to 0.86), 0.83 (95% CI 0.79 to 0.86), and 0.81 (95% CI 0.77 to 0.84), respectively, whereas the pooled mean of the lowest accuracy, sensitivity, specificity, and precision were 0.66 (95% CI 0.63 to 0.69), 0.63 (95% CI 0.58 to 0.68), 0.60 (95% CI 0.55 to 0.66), and 0.64 (95% CI 0.58 to 0.70), respectively. CONCLUSIONS ASA shows promise as a method for detecting depression, though its readiness for clinical application as a standalone tool remains limited. At present, it should be regarded as a complementary method, with potential applications across diverse contexts. Further high-quality, peer-reviewed studies are needed to support the development of robust, generalizable models and to advance this emerging field. CLINICALTRIAL PROSPERO CRD42023444431; https://www.crd.york.ac.uk/PROSPERO/view/CRD42023444431